|
Fibromyalgia
Citations 31-40 of 46 total displayed.
|
Past content
(since Feb 2001):
|
- Review
Fibromyalgia and the therapeutic domain. A philosophical study on the origins of fibromyalgia in a specific social setting
- I. Hazemeijer and J. J. Rasker
Rheumatology 2003; 42: 507-515.
[Abstract]
[Full Text]
- Letters to the Editor
Increased plasma endothelin-1 levels in fibromyalgia syndrome
- M. Pache, J. Ochs, E. Genth, R. Mierau, T. Kube, and J. Flammer
Rheumatology 2003; 42: 493-494.
[Extract]
[Full Text]
- Letters to the Editor
The dilemma of pseudovasculitis and aortic mural thrombi: can trans-oesophageal echocardiogram solve the problem early?
- A. F. A. Helmy and M. H. Husaini
Rheumatology 2003; 42: 494-495.
[Extract]
[Full Text]
- Original Papers
Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals
- M.-A. Fitzcharles and P. Boulos
Rheumatology 2003; 42: 263-267.
[Abstract]
[Full Text]
- Letters to the Editor
Adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome
- J. H. Raphael, J. L. Southall, and G. D. Kitas
Rheumatology 2003; 42: 185-186.
[Extract]
[Full Text]
- Original Papers
Are advanced glycation end-product-modified proteins of pathogenetic importance in fibromyalgia?
- G. Hein and S. Franke
Rheumatology 2002; 41: 1163-1167.
[Abstract]
[Full Text]
- Editorials
The muscle in fibromyalgia
- A. Bengtsson
Rheumatology 2002; 41: 721-724.
[Extract]
[Full Text]
- Original Papers
A case–control study examining the role of physical trauma in the onset of fibromyalgia syndrome
- A. W. Al-Allaf, K. L. Dunbar, N. S. Hallum, B. Nosratzadeh, K. D. Templeton, and T. Pullar
Rheumatology 2002; 41: 450-453.
[Abstract]
[Full Text]
- Original Papers
Investigation of cutaneous microvascular activity and flare response in patients with fibromyalgia syndrome
- A. W. Al-Allaf, F. Khan, J. Moreland, J. J. F. Belch, and T. Pullar
Rheumatology 2001; 40: 1097-1101.
[Abstract]
[Full Text]
- Report
Outcome measures and classification criteria for the rheumatic diseases. A compilation of data from OMERACT (Outcome Measures for Arthritis Clinical Trials), ILAR (International League of Associations for Rheumatology), regional leagues and other groups
- P. Brooks and M. Hochberg
Rheumatology 2001; 40: 896-906.
[Extract]
[Full Text]
|
|
